Altium Capital Management LP Ocular Therapeutix, Inc Transaction History

Altium Capital Management LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$4.09 - $6.5 $727,476 - $1.16 Million	-177,867 Reduced 25.59%	517,133 $2.15 Million
Q4 2021 Feb 14, 2022	BUY	$6.16 - $12.07 $856,240 - $1.68 Million	139,000 Added 25.0%	695,000 $4.84 Million
Q3 2021 Nov 17, 2021	SELL	$9.7 - $14.34 $1.35 Million - $1.99 Million	-139,000 Reduced 20.0%	556,000 $5.56 Million
Q3 2021 Nov 15, 2021	BUY	$9.7 - $14.34 $4.26 Million - $6.29 Million	438,848 Added 171.32%	695,000 $4.81 Million
Q2 2021 Aug 13, 2021	SELL	$13.43 - $19.16 $940,395 - $1.34 Million	-70,022 Reduced 21.47%	256,152 $3.63 Million
Q1 2021 May 06, 2021	BUY	$15.82 - $22.11 $363,860 - $508,530	23,000 Added 7.59%	326,174 $5.31 Million
Q4 2020 Feb 16, 2021	BUY	$7.91 - $22.95 $2.4 Million - $6.96 Million	303,174 New	303,174 $6.28 Million

189

132M

374K

179K

Ticker OCUL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,966,896
Market Cap $560M
Description
Ocular Therapeutix, Inc., a biopharmaceutical company, focuses on the formulation, development, and commercialization of therapies for diseases and conditions of the eye using its bioresorbable hydrogel-based formulation technology. The company markets ReSure Sealant, an ophthalmic device to prevent wound leaks in corneal incisions following cat...

Get notified when there are updates to the investment portfolio of Altium Capital Management LP, based on Form 13F filings with the SEC.

Stay updated on Altium Capital Management LP with notifications on news.